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Abstract Aneurysmal subarachnoid haemorrhage (SAH) is a
disease with devastating complications that leads to stroke,
permanent neurological deficits and death. Clinical and ex-
perimental work has demonstrated the importance of the
contribution of delayed cerebral vasospasm (DCVS)
indepen-dent early events to mortality, morbidity and func-
tional out-come after SAH. In order to elucidate processes
involved in early brain injury (EBI), animal models that reflect
acute events of aneurysmal bleeding, such as increase in
intracranial pressure (ICP) and decrease in cerebral perfusion
pressure, are needed. In the presented arterial shunt model,
bleeding is initially driven by the pressure gradient between
mean arterial blood pressure and ICP. SAH dynamics (flow
rate, volume and duration) depend on physiological reactions
and local anatomical intrathecal (cistern) conditions. During
SAH, ICP reaches a plateau close to diastolic arterial blood
pressure and the blood flow stops. Historical background,
anaesthesia, perioperative care and monitoring, SAH induc-
tion, technical considerations and advantages and limitations
of the rabbit blood shunt SAH model are discussed in detail.
Awareness of technical details, physiological characteristics
and appropriate monitoring methods guarantees successful
implementation of the rabbit blood shunt model and allows
the study of both EBI and DCVS after SAH.
Keywords Subarachnoid haemorrhage . Animal models .
Rabbit . Arterial blood shunt . Early brain injury . Delayed
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Introduction
Aneurysmal subarachnoid haemorrhage (SAH) is a disease
with devastating complications that leads to stroke, permanent
neurological deficits and death. Despite major improvements
in surgical techniques, diagnosis and interventional treatment,
average case fatality rates for SAH remain between 40 and
50% [1], and only 60% [2] of surviving patients will return to
work. The disease mainly affects relatively young patients,
causing significant socioeconomic impact [3].
Following the first description of delayed cerebral vaso-
spasm (DCVS) after aneurysm rupture by Ecker and
Riemenschneider [4] in 1951, DCVS was believed to be the
main cause of ischemia, infarction and poor patient outcome.
In 1997, endothelin A receptor (ET-1A) antagonists were
found to prevent DCVS after SAH in a double cisterna magna
autologous blood injection model in rats [5]. One year, later
these promising results were confirmed in a single-
haemorrhage cisterna magna injection rabbit model [6].
After publication of phase, the 2a [7] and 2b [8] multi-centre
study results, the phase 3 [9] trial demonstrated no statistically
significant effect on DCVS-related morbidity, mortality or
functional outcome.
Clinical and experimental work has long demonstrated the
importance of DCVS-independent early events after SAH
[10–12]. However, the disappointing results of the phase-3
ET-1A antagonist study have led to increased interest in the
phenomenon of early brain injury (EBI) after SAH. The
change of focus was interpreted as a paradigm shift from
DCVS to EBI [13–15]. EBI is an umbrella term that covers
complex pathophysiological mechanisms occurring within the
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first few days after aneurysm rupture. The triggers and bio-
logical mechanisms that cause EBI are just being discovered
and are not yet fully understood. Increase in intracranial
pressure (ICP) during aneurysm rupture and the associated
sequels are believed to be crucial to the pathophysiologies that
develop in EBI following acute SAH.
According to the previous paradigm stating that DCVS is
the main contributor to poor clinical outcomes after SAH,
most animal models have traditionally been designed to pro-
duce consistently high degrees of DCVS but not to reflect
acute events of SAH. Until 2007, rat and rabbit animal models
were the most often used for the study of DCVS [16]. In the
rabbit, virtually all studies (98 %) were performed using the
cisterna magna blood injection technique (84 % single and
14 % multiple injections). In order to elucidate processes
involved in EBI, animal models that reflect acute events of
aneurysmal bleeding (such as increase in intracranial pressure
[ICP] and decrease in cerebral perfusion pressure [CPP]) are
needed [13]. To overcome limitations of current experimental
SAH techniques, we developed an examiner-independent
controllable SAH rabbit model that simulates early events of
aneurysm rupture and triggers moderate to severe degrees of
DCVS. The dynamics of the “spontaneous” bleeding into the
subarachnoid space depend solely on the rabbit’s anatomical
and physiological conditions.
The Rabbit Model of Subarachnoid Haemorrhage
Historical Background, Evolution and Modification Over
the Years
In the early 1980s, the rabbit emerged as a new species for
DCVS research. Initially, Edvinsson et al. [17] injected autol-
ogous blood into the prechiasmatic and basal cistern. In the
ensuing years, other researchers simplified the route through
either open or transcutaneous injection into the cisternamagna
[18–21]. Over time, the single cisterna magna injection be-
came the gold standard for SAH induction in rabbits [16]. The
multiple blood injection model was considered controversial
among experts, leading to the deferral of its use. In 1989,
Spallone and Pastore [22] evaluated the double-haemorrhage
approach and found that multiple injections did not enhance
DCVS, but are associated with an increased rate of mortality
(>50 %). In 2007, Zhou was the first to present that the
modified double-haemorrhage model (percutaneous injection
and longer time interval between injections) produced signif-
icantly more severe DCVS and a very low rate of mortality
(6 %) in a direct comparison of single and double blood
injection [23].
Logothetis et al. made the first attempt to establish the
rabbit model for the examination of both acute and late events
after SAH [24]. They punctured the posterior branch of the
middle cerebral artery and superior sagittal sinus. Egemen
et al. performed a basilar artery puncture from a transclival
approach [25]. Although both models do simulate acute SAH
through arterial bleeding into the subarachnoid space in a
closed cranium (if the skull is adequately closed), the models
have not been validated for the study of EBI and have never
been replicated since their original publication. In addition,
puncture models have been criticised for their extensive intra-
cranial manipulation.
The concept of simulating arterial subarachnoid bleeding
within a closed cranium by shunting an artery into the sub-
arachnoid space is not new and has been described in dogs
[26, 27], cats [28], rabbits [29] and rats [30] (Fig. 1). Offerhaus
and van Gool [29] were the first to use an artery-cisternal
shunt (carotid artery-chiasmatic cistern) to induce acute ex-
perimental SAH and to study electrocardiographic changes
and catecholamine release. Steiner et al. [26] produced an
intrathecal haemorrhage by shunt from the femoral artery to
Fig. 1 Various models of shunt-induced SAH. This drawing demon-
strates various shunt techniques in different species. In rats and rabbits, a
polyethylene tube in the prechiasmatic cistern was connected to the left
common carotid artery (*). In cats, a catheter placed in the abdominal
aorta (**) was connected with a needle in the prechiasmatic cistern. In
dogs, a cannula was placed at various cranial sites and connected to the
left femoral artery (***). In the presented blood shunt SAH rabbit model,
the left subclavian artery (●) is cannulated and connected via three-way
stopcock to the paediatric spinal tap needle placed in the cisterna magna.
(Reprinted with permission of Br J Neurosurgery, Standard intracranial
in vivo animal models of delayed cerebral vasospasm byMarbacher et al.
2010. Copyright 2010 by Informa Healthcare)
670 Transl. Stroke Res. (2014) 5:669–680
one of four intracranial sites (cerebral parenchyma, cisterna
chiasmatica, lateral ventricle and cisterna magna) to examine
the role of multiple bleeding sites in relation to localisation,
ICP increase and vital functions. McCormick et al. [27]
adapted the femoral-cisternal shunt described by Steiner
et al. by adding a pressurised reservoir that allowed only
unidirectional flow and examined the mechanisms of SAH
arrest. Zhao et al. simulated the acute period of SAH using a
rat common carotid artery-prechiasmal extracorporeal
shunt to study the phenomenon of sudden death.
Trojanowski [28] used abdominal aorta-perichiasmatic
shunt model in cats to study dynamics of SAH regard-
ing flow, volume and time of blood extravasation into
the subarachnoid space.
The models were introduced to overcome shortcomings in
blood injection (arbitrary ICP increase) and vessel puncture
models (missing control of severity of bleeding) while study-
ing acute events during SAH. The refined shunt-induced
models induce controllable bleeding in terms of ICP increase
and amount of blood being distributed in the subarachnoid
space. However, the shunt model of SAH has only been
recently evaluated in rabbits for the study of DCVS [31] or
EBI [32].
The Rabbit Subarachnoid Haemorrhage Shunt Model
Description of Animals Used
New Zealand white rabbits are timid, nonaggressive, easy to
handle and relatively inexpensive to maintain. They are kept
in rooms with controlled temperature (20±2 °C), 50 % hu-
midity, under a 12-hour/12-hour day-night cycle. Food pellets
(they eat throughout the day) and tap water (up to 100 ml/kg/
day) are provided without restriction. Unfortunately, isosexual
group-housing of male animals inevitably leads to severe
fighting, reflecting the biological intolerance of male rabbits.
As rabbits must be housed in groups (two to four per cage,
with the exception of sick animals and those recovering from
anaesthetic) due to animal welfare regulations, female animals
are preferred. Using females, however, increases the risk of
estrogens attenuating SAH-induced apoptosis [33].
With the exception of haematocrit values, whole blood
haemoglobin concentration, percentage of granulocyte and
serum potassium concentration, there are no statistically sig-
nificant differences in haematological and biochemical normal
values between male and female animals [29]. Young (2-
month-old, growing) rabbits demonstrate altered haematolog-
ical and biochemical characteristics as compared to adult (2-
year-old) rabbits [34]. One interesting finding is that the time
course of DCVS depends on the rabbits’ age. In young rabbits,
arterial calibre returned almost to baseline 7 days after SAH,
whereas older rabbits (20 to 40 months) showed continuous
vasospasm with near maximal constriction 1 week after initial
iatrogenic bleeding [35]. The physiological parameters are
summarised in Table 1.
Details of Anaesthesia and Analgesia, Perioperative Care
and Monitoring
General anaesthesia in the rabbit is induced through intramus-
cular injection of ketamine (30 mg/kg; Ketalar, 50 mg/ml) and
xylazine (6 mg/kg; Xylapan 20 mg/ml). Depth of anaesthesia
is controlled by testing the rabbit’s response to noxious stim-
ulation (e.g. toe-pinch), decrease of palpebral and corneal
reflexes and extent of muscle relaxation. In case of positive
response to noxious stimulation, the depth of anaesthesia is
adapted by ketamine bolus (6 mg/kg) i.v. and xylazine bolus
(0.05 mg/kg) i.v. and/or an additional analgesia bolus with
fentanyl (1 mcg/kg) i.v. Due to the half-life of ketamine and
xylazine, the recovery time of control (sham-operated) ani-
mals is quite short (approximately 1 h). Delayed recovery time
(approximately 3 h) can be expected in animals after blood
shunt induction. Transdermal fentanyl patches releasing
12.5μg/h are applied to the shaved neck region of the animals,
providing effective analgesia for the following 72 h. A veter-
inary anaesthesiologist monitors the animals during surgery
and throughout anaesthetic recovery. The animals are not
returned to the company of other animals until they regain
sufficient consciousness.
The direct influence of different anaesthetics on neuronal
cells (neuroprotective and neurotoxic) and potential influence
on pathophysiology (changes in cerebral metabolic rate, ICP,
CPP, systemic blood pressure) and outcome after experimen-
tal SAH in rabbits remains—to the best of our knowledge—
unexplored. In rats, the striking impact of anaesthesia on
pathophysiology following SAH has been demonstrated
[36]. It remains unknown whether, and to what extent, the
use of ketamine (an antagonist of NMDA receptors)/ xylazine
(agonist at the α2 class of adrenergic receptor) anaesthesia
compromise neuronal cell death after SAH in the blood shunt
model presented. Nevertheless, the impact of the acute SAH
on apoptosis can be highlighted by the differences observed
between SAH animals and sham controls [32]. Furthermore,
one also needs to keep in mind that anaesthesia can change
physiological blood gas status [37]. Different use of combi-
nations of sedatives and opioids significantly influences de-
crease in respiratory rate and degree of hypoxemia and hyper-
capnia evidenced by arterial blood gas analysis [38]. This is of
particular importance as pCO2 influences cerebral artery di-
ameter [39, 40]. While in mechanically ventilated rabbits,
blood gas values can be kept in a physiologic range and
mortality due to respiratory arrest during acute SAH is re-
duced, it remains a matter of debate whether experimental
SAH in spontaneously breathing animals (or awake animals
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[41]) mimics the human situation of aneurysm rupture more
closely.
In our experimental setting, the following physiological
parameters are routinely monitored during the experiments:
heart rate, electrocardiogram, core temperature, arterial blood
pressure, peripheral oxygen saturation, respiratory rate (based
on end expiratory carbon dioxide curve), core temperature,
cerebral blood flow in the right and left hemisphere and
intracranial pressure. The following laboratory parameters
are assessed: pH, partial pressure of carbon dioxide (pCO2),
partial pressure of oxygen (pO2), sodium (Na
+), potassium
(K+), glucose (Glu), lactate (Lac), haematocrit level,
haemoglobin (Hb), actual bicarbonate (HCO3
−), total carbon
dioxide content (TCO2), bases excess (BEb) and calculated
oxygen saturation (SO2c).
After SAH, we keep the animals under close observation
for at least 3 h. Afterwards, the neurological status is graded at
6, 12, 24, 48 and 72 h post-SAH according to the four-point
grading system reported by Endo et al. [20]: grade 1, no
neurological deficit; grade 2, minimal or suspected neurolog-
ical deficit; grade 3, mild neurological deficit without abnor-
mal movement; and grade 4, severe neurological deficit with
abnormal movement. Food intake is recorded as none, re-
duced or normal. During the first 3 h, sham-operated controls
recover significantly faster than rabbits which have undergone
blood shunt-induced SAH. SAH rabbits show progressive
aggravation of neurological deficits on days one to three
[31]. Drowsiness and reduced movements are noted in most
animals after SAH. Focal neurological deficits such as severe
limb weakness or hemiparesis are rare [31, 32]. SAH animal
mortality can rise to 18–25 % due to respiratory arrest and
severe bradycardia during peak ICP [31, 32].
Detailed Description of SAH Induction
Technical aspects and a detailed standard operating procedure
of the blood shunt SAHmodel in the rabbit is given elsewhere
[42]. In brief, the most important steps are the following: (1)
Table 1 Selected physi-
ologic parameters in
New Zealand white
rabbits
a Haematological param-
eters measured in the
blood of adult female
New Zealand rabbits
[66]
b Blood gas parameters
in adult (~3 kg) female
New Zealand rabbits
without anaesthesia.
Please see text for expla-
nation of abbreviations
[37]
Physiological parameters Values
Body weight 2–6 kg
Body temperature 38.5–39.5 °C
Heart rate 120–300/per min
Respiratory rate 30–120/min
Total ventilation 0.8 l/min
Water consumption 120 ml/kg/day
Food consumption 100–300 g/day
Mean life span 8 years
Sexual maturity age 4–6 months
Intracranial pressure 5–10 mmHg
Brain weight 14 g
Basilar artery diameter 600–800 μm
Haematological parametersa Values (mean±SEM) Range
HTC (%) 42.2±1.1 33.1–47.7
Haemoglobin (g/dl) 14.8±5.4 10.8–17.5
White blood count (×106/mm3) 10.4±1.1 5.8–20.1
Granulocytes (×106/mm3) 6.6±0.9 1.7–14.7
Total protein (g/l) 62.5±2.2 49–79
Glucose (mmol/l) 6.6±0.3 4.9–8.3
Ca2+ (mmol/l) 3.0±0.1 2.5–3.7
Na+ (mmol/l) 141.6±0.5 139.3–145.7
K+ (mmol/l) 4.1±0.1 3.0–4.7
Blood gas parametersb Values (mean±SEM)
pH 7.44±0.04
pCO2 (mmHg) 32.4±1
pO2 (mmHg) 88±3
HCO3
− (mmol/l) 22.5±1.2
TCO2 (mmol/l) 23.5±1.2
BEb (mmol/l) −0.2±1.4
SO2c 96.9±0.9 %
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firstly, (supine position) the left subclavian artery is cannu-
lated. (2) In the second step, digital subtraction angiography of
the basilar artery is performed by retrograde injection of
contrast agent. (3) Then, the animal is repositioned (prone
position), neuromonitoring probes are installed (according to
outer skull landmarks [43]), and a spinal access needle is
inserted into the cisternamagna. (4) In the final step, the spinal
access needle and the subclavian artery are connected to a
shunt. The SAH can be initiated by opening the shunt,
allowing the blood to stream into the subarachnoid space
under arterial pressure.
Sham-operated animals undergo neuromonitoring place-
ment and puncture of the cisterna magna. A saline control
group could theoretically be performed using a pressurised
reservoir similar to that previously used in dogs (60 ml, under
mean arterial blood pressure [MABP] +/−5 mmHg) [27]. The
volume of applied blood can be measured with a flow probe
interposed in the shunt between the subclavian artery and the
cisterna magna (Fig. 2) [31]. During SAH, ICP reaches a
plateau close to diastolic arterial blood pressure, and then the
flow in the shunt stops and allows the blood to coagulate. At
that time, cerebrospinal fluid is completely displaced from the
cisterna magna and effective clot formation occurs. The small
amount (a few millilitre) of arterial blood lost for SAH induc-
tion does not cause hypovolemia and is not replaced nor is
additional fluid provided until complete recovery.
In order to prevent “re-bleeding”we close the shunt when a
plateau phase (ICP = diastolic blood pressure) is maintained
for more than 10 s or ICP decreases spontaneously. Apart
from this “spontaneous” stop of bleeding through coagulation,
the shunt can also be closed at any point. This “controlled”
SAH allows simulation of various degrees of bleeding by
means of ICP increase or extravasated subarachnoid blood
volume (provided that the shunt flow is measured).
After SAH induction, the neuromonitoring (ICP and cere-
bral blood flow [CBF] fine-needle probes) are removed and
the burr holes sealed with bone wax. The subclavian artery
catheter is carefully removed and ligated. Wounds are irrigat-
ed thoroughly with neomycin sulphate and sutured. For
follow-up angiography, the animals undergo the same anaes-
thesia protocol as described above. The right subclavian artery
is cannulated and digital subtraction angiography (DSA) is
performed by retrograde intra-arterial bolus injection of non-
ionic iopamidol (0.6 ml/kg, for 1 to 2 s) through the cannu-
lated artery (Fig. 3). The cannula needs to be flushed with
saline immediately after bolus contrast agent injection in order
to prevent occlusion of the latter. Inmost cases, single baseline
and follow-up angiography is needed for evaluation of DCVS
over time, and hence, the most pragmatic way is to sacrifice
the left and right subclavian artery for each angiography.
However, if multiple baseline or follow-up angiographies are
required, we suggest to consider selective angiography
through the femoral artery and microcatheter placement in
the brachiocephalic artery.
Gross Examination of Brain and Pathophysiology
The anatomy, adhesions in the subarachnoid space and
cerebroventricular system in rabbits are largely different from
that of humans [44]. During acute blood shunt-induced SAH
Fig. 2 Experimental setting. a Entry point for the percutaneous place-
ment of the paediatric spinal tap needle into the cisterna (small dashed
circle) and area of midline incision over the skull where the
neuromonitoring is placed according to outer skull landmarks (large
dashed circle). b The cannulated subclavian artery (*) is connected via
three-way stopcock and pressure tube with the spinal tap needle placed in
the cisterna magna (**). A flow probe (1.5 mm diameter, 2.4 MHz
ultrasound flowprobe, Transonic Systems Inc., Ithaca, NY, USA)
mounted on the pressure tube (inlet, an interposed rabbit aortic graft is
needed to get accurate readings of flow) facilitates measurement of blood
volume streaming under arterial pressure into the closed cranium
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there is no significant pressure gradient between the
infratentorial and supratentorial compartment and free cere-
brospinal fluid communication results in equal subarachnoid
blood distribution at the ventral and dorsal surface of the brain
and in supra- and infratentorial cisterns (chiasmatic and
prechiasmatic cistern, basal cistern, prepontine and
interpeduncular cisterns, and cistern magna) [31, 45, 32].
Unpublished data of recent experimental studies suggest that
there is no correlation between increase in ICP and amount of
blood distributed in the subarachnoid space.
Under general anaesthesia, intracardiac perfusion-fixation
is carried out at room temperature with 400 ml of 0.1 M
phosphate-buffered solution (PBS) followed by 400 ml fixa-
tive (4 % paraformaldehyde in 0.1 M PBS, pH 7.3) under a
perfusion pressure of 0.1 bar. The brains are carefully re-
moved from the skull and the basal and hemispheric surfaces
are photographed. The amount of SAH is quantified accord-
ing to a slightlymodified grading system previously published
by Sugawara et al. [46]: 0, no blood; 1, minimal blood; 2,
moderate blood clot (basal arteries visible); and 3, massive
blood clot (visual obliteration of basal arteries). This bleeding
scale is applied to the (1) chiasmatic and prechiasmatic cistern,
(2) basal cistern, (3) prepontine and interpeduncular cistern,
and (4) cistern magna. The summed score of all four cistern
(range 0–12) determine the final grade of mild (0–4), moder-
ate (5–8) or severe (9–12) grade of SAH. One day after shunt-
induced SAH more than 80 % of the animals demonstrate a
severe SAH sum score of 10 to 12.
Despite the fact that blood streams under arterial pressure
into the subarachnoid space intracerebral haematomas at the
level of the brainstem do not occur. Intraventricular haemor-
rhage in the lateral and fourth ventricle is a rare finding. When
precautions of meticulous and tight sealing of the burr holes as
well as aseptic techniques in combination of antibiotic wound
irrigation are followed, then it is highly unlikely that signs of
cerebrospinal fluid leakage or wound infections will occur
[42].
Opening the shunt allows arterial blood to stream under
arterial pressure into the subarachnoid space. The bleeding
pulsates, with systolic pressure peaks causing disruption of the
delicate connective tissue strands of the arachnoid trabeculae
and mechanical stress to cerebral artery walls. Brisk increases
in ICP and decreases of CPP to almost zero results in global
ischemia.
Within 2 to 3 min after shunt-induced SAH, ICP rise to
peak values close to diastolic arterial blood pressure values.
Within 5 to 10 min, ICP then returns to a steady state (signif-
icantly higher than baseline values). During the first 3 min of
acute SAH, CPP drops significantly and CBF decreases equal-
ly in both hemispheres to approximately 20–30 % of baseline
values [32]. Augmentation of mean arterial blood pressure is
frequently observed during the peak phase of SAH (Cushing
reflex). As a result of the Cushing reflex, CPP recovers early
after SAH induction. The heart rate regularly decreases after
an initial increase at the time of SAH initiation.
These severe pathophysiological disturbances and their
subsequent consequences cause early microclot formation,
significant damage to the hippocampus, basal cortex and
cerebral vasculature 24 h after shunt-induced SAH and trig-
gers marked basilar artery vasoconstriction 72 h after initial
bleeding [45, 32, 31]. Pathophysiological events caused by
shunt-induced SAH are summarised in Table 2 and Fig. 4.
Technical Considerations
All surgical procedures are performed under sterile con-
ditions. The most critical considerations and surgical
steps required to ensure consistency and accuracy of
the rabbit shunt SAH model are as follows: (1) age of
the rabbit should not exceed 3–4 months in order to
avoid increased mortality and prolonged DCVS [35], (2)
secure ligatures of the subclavian artery are needed to
prevent twisting or slippage of the catheter during care-
ful repositioning from prone to supine position [42], (3)
tight sealing of the burr holes (ICP and CBF monitoring
probes) is essential to maintain a closed cranium condi-
tion [42], (4) calibration of the angiogram (using an
external reference marker during DSA) must be carried
out to ensure minimal bias in image post-processing
[47], and (5) percutaneous puncture of the cisterna
magna should be performed carefully and slowly using
the external occipital protuberance (located through di-
rect palpation) as a landmark (Fig. 5). Step-by-step
procedural instructions, necessary equipment and techni-
cal nuances to perform the rabbit blood shunt SAH
model with minimal mortality and morbidity are given
elsewhere [42].
Fig. 3 Digital subtraction angiography. Digital subtraction angiography
of the basilar artery (black arrows) is performed by retrograde intra-
arterial bolus injection of nonionic Iopamidol (0.6 ml/kg, for 1 to 2 s)
through the left (baseline) and right (follow-up) subclavian artery. An
external sizing device (*) is used as reference marker to minimise bias in
image post-processing and measurement of the basilar artery diameter
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Discussion of Advantages and Limitations in Comparison
with Other Models and Techniques
There are two principle methods to simulate bleeding in the
subarachnoid space close to the large cerebral vessels. Either
the blood is added from outside (via blood injection or crani-
otomy and blood clot placement) or an intracranial artery is
injured (vessel puncture or rupture). Craniotomy and blood
clot placement is technically challenging and results in poten-
tial mechanical irritation of the intracranial arteries and
periarterial environment (the tamponading effect of the cistern
during bleeding no longer exists, subdural and subarachnoid
spaces are connected to each other). Injection of blood
(as far as it is performed stereotactically and percutane-
ous) is a minimally invasive, simple and fast procedure,
but the choice of injection dynamics (pressure and time)
as well as volume are often arbitrary [16]. Neither of
the two techniques where blood is added from the
exterior closely reproduces pathophysiological sequels
of aneurysm rupture.
Endoluminal puncture is very suitable to induce SAH
as it closely mimics aneurysm rupture (arterial bleeding
of pulsatile character within a closed cranium) [48, 49].
In contrast to all other intracranial artery injury models,
the endovascular puncture model avoids any extensive
intracranial manipulation associated with vessel puncture
and vessel rupture through skull openings or implant
device placement [50, 51, 25, 24, 41, 52, 53].
Nevertheless, no vessel injury model allows exact con-
trol of bleeding volume, time course or severity of ICP
increase.
In the arterial shunt model, bleeding is initially driven by
the pressure gradient between mean arterial blood pressure
and ICP. Further SAH dynamics (flow rate, volume and
duration) depend on physiological reactions and local anatom-
ical intrathecal (cistern) conditions [27, 26]. Important phys-
iological reactions such as the pulsatile character of the bleed-
ing (pressure peaks), the Cushing phenomenon, ECG and
EEG changes and development of mechanical resistance to
repeated bleeding are documented using the arterial shunt
model [26].
The lack of damage and exposure of the artery wall in the
shunt model could potentially be regarded as source of bias.
However, the aneurysm wall and site of rupture is significant-
ly different than a healthy intracranial vessel wall. The rup-
tured aneurysm wall consists of a degenerated, almost
decellularized, thin layer missing endothelial cells [54, 55].
Acute arterial spasm seems not to play a decisive role in
spontaneous haemostasis in intracranial bleeding [26].
Intracranial counter-pressure based on anatomical factors spe-
cific for each bleeding site and not premature coagulation in
the tube system appear to be the main factor in cessation of
blood flow [27, 26].
There are only a limited number of neurological scales for
testing motor, sensory and reflex functions after SAH in
rabbits [56, 16]. Clinical assessment has also been performed
using open-field locomotor activity and scoring of the rabbit’s
appetite [57, 20]. Neurobehavioural testing of rabbits after
SAH has not yet been described. Nevertheless, the relation-
ship between neurological function (assessed in simple 4–6
scale scores) and severity of DCVS after SAH in rabbits is
well established [56].
Single cisterna magna blood injection in rabbits dem-
onstrates maximal vasoconstriction on day 2–4 after
SAH with vessel narrowing ranging from 19 to 55 %
when compared to baseline vessel diameter [16].
Additional blood injection postpones peak onset until
day 7 with debated enhancement of DCVS (15–20 %
[22], 23 %[20]). In direct comparison of single and
double blood injection method, more severe morphomet-
ric (cross section area and artery wall thickness) vaso-
spasm was documented in the double cisterna magna
injection group [23]. In our experience, only mild
Table 2 Evolution of hemodynamic parameters and outcome data in
New Zealand white rabbits at baseline, during and after shunt-induced
subarachnoid haemorrhage
Parameters Values
Baseline
MABP (mmHg) 71±2
ICP (mmHg) 7±1
CPP (mmHg) 63±2
CBF (%) 100
Peaka
MABP (mmHg) 81±5
ICP (mmHg) 54±5
CPP (mmHg) 23±3
CBF (%) 34±4
Steady state
MABP (mmHg) 71±2
ICP (mmHg) 20±1
CPP (mmHg) 51±2
CBF (%) 78±6
DCVSb ~30–50 % of baseline (on day 3 after SAH)
Mortality rate ~15–25 % (respiratory arrest/bradycardia)
Neurological deficitsc >90 % grade 3 (on day 3 after SAH)
SAH sum scored >80 % score 10 to 12 (on day 1 after SAH)
a Please note that due to the Cushing reflexMABP reaches its peak later in
time than maximal CPP depletion (see text)
b The time course of DCVS after shunt-induced SAH has not yet been
established
c Neurological status graded according to a four-point grading system (see
text)
d SAH quantification according to a 12-point grading system (see text)
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degrees of DCVS were achieved (20 % [58], 14 % [59],
12 % [59], 16 % [60]) using the single injection cisterna
magna model.
Egemen et al. reported the highest degree (68 %) reduction
of angiographic diameter after acute experimental SAH in
rabbits using a transclival craniotomy and basilar artery punc-
ture approach. Initial results of the shunt-induced SAH tech-
nique revealed 53 % DCVS. A possible explanation for the
higher degree of DCVS in acute SAHmodels (vessel puncture
and shunt-induced models) as compared to blood injection
models might be early damage to endothelial cells [61, 62]
which may aggravate DCVS. Vessel damage along with brain
injury by means of neurodegeneration and apoptosis in the
hippocampus CA1 and CA3 as well as basal cortex regions
has been demonstrated 24 h after shunt-induced SAH in
rabbits.
One specific advantage of the rabbit SAH model is that
DSA can be readily applied to determine the degree of cerebral
artery reduction over time. Basilar angiograms are performed
either nonselectively using retrograde contrast agent injection
through the cannulated subclavian artery (standard procedure)
or by selective vertebral artery catheterization via the femoral
artery [47]. DSA is still considered the gold standard for
evaluating DCVS. Although DSA does not achieve similar
spatial resolution as compared to morphometric determination
of vessel diameter, it allows assessment of the entire artery
length at different time points in the same animal.
In order to perform histological evaluation, arteries
must be removed from their natural environment; chro-
nological observation is not possible, and inequality of
sections at different segments is a source of bias. In
addition, formaldehyde fixation can result in basilar
Fig. 4 Pathophysiological
parameters. a ICP increases to
peak values close to diastolic
blood pressure and returns to a
steady state significantly higher
than baseline values. b The
increase in ICP causes a
significant increase in MABP. c
During the acute phase of the
bleeding, CPP decreases but
demonstrates a fast recovery,
thanks to the compensatory
increase in MABP. d At the time
of SAH, marked reduction in
CBF occurs in both hemispheres
and recovers to 70 % of baseline
values within 20 min. e
Screenshot of typical waves of
heart rate (HR), arterial blood
pressure (ABP), intracranial
pressure (ICP), cerebral blood
flow left (CBF1) and right
(CBF2) hemispheres after
induction of SAH (dashed line)
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artery calibre changes to such a degree that morphomet-
ric assessment of formaldehyde-fixed basilar arteries
becomes unreliable [63].
Although real basilar artery diameter is most likely
overestimated on CTA (control BA diameter male New
Zealand white rabbits weighing 2.2–2.7 kg, 1,240 μm [64];
male Japanese white rabbits weighing 2.3–2.6 kg, ~1,100 μm
[65]; male New Zealand white rabbits weighing 2.5–3.5 kg,
~800 μm [66]; male albino rabbits, ~1,400 μm [67]), relative
reduction can be assessed noninvasively at various time
points. An alternative method to noninvasive assessment of
DCVS is transcranial Doppler sonography measurement of
mean blood flow velocity and transoccipital peak systolic
velocity [65, 68].
The most important advantages and limitations of the
rabbit shunt-induced SAH model are summarised in
Table 3.
Conclusions
Awareness of technical details, physiological characteristics
and appropriate monitoring methods guarantees successful
implementation of the rabbit blood shunt model and allows
the study of both EBI and DCVS after SAH. Improvement
and refinement of clinical outcome measures, introduction of
a saline control procedure and determination of the exact
DCVS time course will further advance the model and help
elucidate complex SAH sequelae and the screening of potential
treatment modalities.
Fig. 5 Cisterna magna puncture. a The rabbit is placed in prone position
with the head fixed in a head holder. The external occipital protuberance
(red dashed line) is readily located through direct palpation. The needle is
then moved caudally in the midline orthogonally to the bony external
occipital protuberance until a gap (* = cisterna magna) is detected. b The
needle is then carefully and slowly pushed into the gap between the
occipital bone and the atlas (dashed black circle). c Penetration of the
atlanto-occipital membrane can be felt as loss of resistance and the tip of
the needle reaching the middle of the cisterna magna (*, dashed white
circle)
Table 3 Advantages and limitations of blood shunt SAH model in rabbits
Advantages Limitations
Relatively low costs, nonaggressive behaviour,
easy handling of animal
Group-housing of male rabbits might not be possible
(fighting to establish hierarchy)
Mimics acute pathophysiology of aneurysm rupture
with brisk increase in ICP and global ischemia
(equal-sided bi-hemispheric CBF depletion)
Limited availability of specific molecular biological
reagents and transgenic animal models as compared to
other species such as rat and mice
The bleeding is pulsatile and examiner-independent
(driven by the pressure gradient between MAP and ICP)
Relatively high mortality rate of 20–25 % due to respiratory
arrest and severe bradycardia during peak ICP
Provokes physiological reactions such as Cushing
phenomenon and decrease in heart and respiratory rate
Limited neurological scales for testing motor, sensory and
reflex functions. Neurobehavioral tests not yet established
Provokes EBI (24 h) by means of brain (hippocampus
and basal cortex) and vessel damage after acute SAH
The exact time course of DCVS after blood shunt-induced
SAH must still be established
Results in characteristic blood distribution with severe grades of SAH Pressurised reservoir would be needed to establish a saline
control group
Results in moderate to severe DCVS (72 h) after acute SAH
The model allows control over the severity of SAH by means
of ICP increase and/or blood volume
Readily applied DCVS monitoring techniques such as DSA and CTA
Please see text for explanation of abbreviations
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